https://www.fda.gov/media/155050/download
https://www.cdc.gov/coronavirus/2019-ncov/your-health/treatments-for-severe-illness.html
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms or about 88 pounds) with positive results of direct SARS-CoV-2 testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death. Paxlovid is available by prescription only and should be initiated as soon as possible after diagnosis of COVID-19 and within five days of symptom onset.
Treatments
person receiving treatment pamphlet from healthcare provider
The FDA has authorized antiviral medications to treat mild to moderate COVID-19 in people who are more likely to get very sick.
Antiviral treatments target specific parts of the virus to stop it from multiplying in the body, helping to prevent severe illness and death.
The National Institutes of Health (NIH) provides COVID-19 Treatment Guidelines for healthcare providers to help them work with their patients and determine the best treatment options for them. Several options are available for treating COVID-19. They include:
Treatment
Who
When
How
Nirmatrelvir with Ritonavir (Paxlovid)
Antiviral
Adults; children ages 12 years and older
Start as soon as possible; must begin within 5 days of when symptoms start
Taken at home by mouth (orally)
Remdesivir (Veklury)
Antiviral
Adults and children
Start as soon as possible; must begin within 7 days of when symptoms start
Intravenous (IV) infusions at a healthcare facility for 3 consecutive days
Molnupiravir (Lagevrio)
Antiviral
Adults
Start as soon as possible; must begin within 5 days of when symptoms start
楼主
匿名
发表于 2023-1-4 22:41:09
